Related Experiment Video
Updated: Jun 26, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Congenital diaphragmatic hernia: current status and review of the literature
Anthony S de Buys Roessingh1, Anh Tuan Dinh-Xuan
1Service de Chirurgie Pédiatrique, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, 1011, Lausanne, Switzerland. anthony.debuys-roessingh@Chuv.ch
Insights
Congenital diaphragmatic hernia (CDH) treatment is complex. Prenatal tracheal obstruction (TO) and improved postnatal care enhance fetal lung growth and reduce mortality, but challenges remain.
Area of Science:
- Neonatology
- Pediatric Surgery
- Obstetrics
Background:
- Congenital diaphragmatic hernia (CDH) presents significant challenges in neonatology, pediatric surgery, and obstetrics.
- High mortality in CDH is linked to persistent pulmonary hypertension (PPHT) and lung hypoplasia, primarily caused by increased pulmonary arteriole muscularization.
Purpose of the Study:
- To review current management strategies for congenital diaphragmatic hernia.
- To highlight the impact of prenatal interventions and improved postnatal care on patient outcomes.
Main Methods:
- Review of current clinical and experimental research on CDH treatment.
- Analysis of the effects of prenatal tracheal obstruction (TO) and optimized postnatal ventilation.
Main Results:
- Prenatal TO promotes fetal lung growth, increasing alveoli and capillary vessels.
- Postnatal care improvements focus on preventing lung injury via low peak inflation pressure ventilation.
- The efficacy of inhaled nitric oxide and extracorporeal membrane oxygenation (ECMO) remains under debate.
Conclusions:
- While prenatal interventions and improved postnatal care have advanced CDH management, treatment remains challenging.
- Further research is needed to establish universally accepted treatment protocols for CDH.
Abstract:
Treatment of congenital diaphragmatic hernia (CDH) challenges obstetricians, pediatric surgeons, and neonatologists. Persistent pulmonary hypertension (PPHT) associated with lung hypoplasia in CDH leads to a high mortality rate at birth. PPHT is principally due to an increased muscularization of the arterioles. Management of CDH has been greatly improved by the introduction of prenatal surgical intervention with tracheal obstruction (TO) and by more appropriate postnatal care. TO appears to accelerate fetal lung growth and to increase the number of capillary vessels and alveoli. Improvement of postnatal care over the last years is mainly due to the avoidance of lung injury by applying low peak inflation pressure during ventilation. The benefits of other drugs or technical improvements such as the use of inhaled nitric oxide or extracorporeal membrane oxygenation (ECMO) are still being debated and no single strategy is accepted worldwide. Despite intensive clinical and experimental research, the treatment of newborn with CDH remains difficult.
Related Concept Videos
Hiatal Hernia
Pneumothorax II: Pathophysiology
